Lietuva - Antinavikiniai vaistai - Monokloniniai antikūnai metastazavusiam gaubtinės arba tiesiosios žarnos vėžiui gydyti (Cetuximab) ir (ar) (Panitumumab)

different companies won its awards

22

of the awards went to the three most frequent winners

28%

of its calls state an estimated value

11%

Based on 32 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners.

Competition

of the awards went to companies based in another country

0%

As the official award notices state them, over the last 3 years. Tenders per lot count open and restricted procedures only: in a negotiated procedure or a direct award a single tender is the procedure itself. The country is the one the notice gives for the winner.

Lithuania · Medical equipment & pharmaceuticals

different companies won awards here

934

of the awards went to the three most frequent winners

15%

buyers awarded contracts here

82

Based on 2,285 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners.

Competition

tenders per lot on average (open and restricted procedures)

1.9

of those lots received a single tender

35%

of the awards went to companies based in another country

1%

of the tenders came from another country

6%

As the official award notices state them, over the last 3 years. Tenders per lot count open and restricted procedures only: in a negotiated procedure or a direct award a single tender is the procedure itself. The country is the one the notice gives for the winner.